Aldeyra Therapeutics, Inc. - COM (ALDX)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM
Number of holders
103
Total Shares
35.3M
Shares change
-104K
Total reported value, excl. options
$117M
Value change
-$314K
Put/Call ratio
0.32
Number of buys
50
Number of sells
-46
Price
$3.31
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.